Ski-like protein

<p>This section provides any useful information about the protein, mostly biological knowledge.<p><a href='/help/function_section' target='_top'>More...</a></p>Functionⁱ

<p>The <a href="http://www.geneontology.org/">Gene Ontology (GO)</a> project provides a set of hierarchical controlled vocabulary split into 3 categories:<p><a href='/help/gene_ontology' target='_top'>More...</a></p>GO - Molecular functionⁱ

• chromatin binding Source: Ensembl
• DNA-binding transcription factor activity, RNA polymerase II-specific Source: NTNU_SBInferred from sequence modelⁱ
  • "A census of human transcription factors: function, expression and evolution."
    Vaquerizas J.M., Kummerfeld S.K., Teichmann S.A., Luscombe N.M.
    Nat. Rev. Genet. 10:252-263(2009) [PubMed] [Europe PMC] [Abstract]
• DNA-binding transcription repressor activity, RNA polymerase II-specific Source: NTNU_SB <p>Inferred from Direct Assay</p> <p>Used to indicate a direct assay for the function, process or component indicated by the GO term.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#ida">GO evidence code guide</a></p> Inferred from direct assayⁱ
  • "Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein."
    Stroschein S.L., Wang W., Zhou S., Zhou Q., Luo K.
    Science 286:771-774(1999) [PubMed] [Europe PMC] [Abstract]
• protein-containing complex binding Source: UniProtKBInferred from direct assayⁱ
  • "ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells."
    Sarker K.P., Kataoka H., Chan A., Netherton S.J., Pot I., Huynh M.A., Feng X., Bonni A., Riabowol K., Bonni S.
    J. Biol. Chem. 283:13269-13279(2008) [PubMed] [Europe PMC] [Abstract]
• protein domain specific binding Source: UniProtKB <p>Inferred from Physical Interaction</p> <p>Covers physical interactions between the gene product of interest and another molecule (or ion, or complex).</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#ipi">GO evidence code guide</a></p> Inferred from physical interactionⁱ
  • "ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells."
    Sarker K.P., Kataoka H., Chan A., Netherton S.J., Pot I., Huynh M.A., Feng X., Bonni A., Riabowol K., Bonni S.
    J. Biol. Chem. 283:13269-13279(2008) [PubMed] [Europe PMC] [Abstract]
• RNA polymerase II proximal promoter sequence-specific DNA binding Source: NTNU_SBInferred from direct assayⁱ
  • "Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein."
    Stroschein S.L., Wang W., Zhou S., Zhou Q., Luo K.
    Science 286:771-774(1999) [PubMed] [Europe PMC] [Abstract]
• SMAD binding Source: UniProtKBInferred from physical interactionⁱ
  • "The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins."
    He J., Tegen S.B., Krawitz A.R., Martin G.S., Luo K.
    J. Biol. Chem. 278:30540-30547(2003) [PubMed] [Europe PMC] [Abstract]
  • "Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts."
    Jinnin M., Ihn H., Mimura Y., Asano Y., Tamaki K.
    Arthritis Rheum. 56:1694-1705(2007) [PubMed] [Europe PMC] [Abstract]
• transcription corepressor activity Source: UniProtKBInferred from direct assayⁱ
  • "Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein."
    Stroschein S.L., Wang W., Zhou S., Zhou Q., Luo K.
    Science 286:771-774(1999) [PubMed] [Europe PMC] [Abstract]

GO - Biological processⁱ

• blastocyst formation Source: Ensembl
• cell cycle arrest Source: Ensembl
• lens fiber cell differentiation Source: Ensembl
• lymphocyte homeostasis Source: Ensembl
• negative regulation of BMP signaling pathway Source: GO_Central <p>Inferred from Biological aspect of Ancestor</p> <p>A type of phylogenetic evidence whereby an aspect of a descendent is inferred through the characterization of an aspect of a ancestral gene.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#iba">GO evidence code guide</a></p> Inferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief. Bioinformatics 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• negative regulation of cell differentiation Source: GO_CentralInferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief. Bioinformatics 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• negative regulation of transcription by RNA polymerase II Source: UniProtKBInferred from direct assayⁱ
  • "Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein."
    Stroschein S.L., Wang W., Zhou S., Zhou Q., Luo K.
    Science 286:771-774(1999) [PubMed] [Europe PMC] [Abstract]
  • "Sumoylated SnoN represses transcription in a promoter-specific manner."
    Hsu Y.H., Sarker K.P., Pot I., Chan A., Netherton S.J., Bonni S.
    J. Biol. Chem. 281:33008-33018(2006) [PubMed] [Europe PMC] [Abstract]
  • "Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts."
    Jinnin M., Ihn H., Mimura Y., Asano Y., Tamaki K.
    Arthritis Rheum. 56:1694-1705(2007) [PubMed] [Europe PMC] [Abstract]
• negative regulation of transforming growth factor beta receptor signaling pathway Source: UniProtKBInferred from direct assayⁱ
  • "Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts."
    Jinnin M., Ihn H., Mimura Y., Asano Y., Tamaki K.
    Arthritis Rheum. 56:1694-1705(2007) [PubMed] [Europe PMC] [Abstract]
  • "Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis."
    Nanjundan M., Cheng K.W., Zhang F., Lahad J., Kuo W.L., Schmandt R., Smith-McCune K., Fishman D., Gray J.W., Mills G.B.
    Mol Oncol 2:164-181(2008) [PubMed] [Europe PMC] [Abstract]
• neuron development Source: GO_CentralInferred from biological aspect of ancestorⁱ
  • "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium."
    Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D.
    Brief. Bioinformatics 12:449-462(2011) [PubMed] [Europe PMC] [Abstract]
• positive regulation of axonogenesis Source: UniProtKB <p>Inferred from Mutant Phenotype</p> <p>Describes annotations that are concluded from looking at variations or changes in a gene product such as mutations or abnormal levels and includes techniques such as knockouts, overexpression, anti-sense experiments and use of specific protein inhibitors.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#imp">GO evidence code guide</a></p> Inferred from mutant phenotypeⁱ
  • "Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN."
    Stegmuller J., Konishi Y., Huynh M.A., Yuan Z., Dibacco S., Bonni A.
    Neuron 50:389-400(2006) [PubMed] [Europe PMC] [Abstract]
• positive regulation of extrinsic apoptotic signaling pathway via death domain receptors Source: Ensembl
• positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage Source: Ensembl
• protein heterotrimerization Source: UniProtKBInferred from direct assayⁱ
  • "Complex formation between proteins encoded by the ski gene family."
    Nagase T., Nomura N., Ishii S.
    J. Biol. Chem. 268:13710-13716(1993) [PubMed] [Europe PMC] [Abstract]
• protein homotrimerization Source: UniProtKBInferred from direct assayⁱ
  • "Complex formation between proteins encoded by the ski gene family."
    Nagase T., Nomura N., Ishii S.
    J. Biol. Chem. 268:13710-13716(1993) [PubMed] [Europe PMC] [Abstract]
• response to antibiotic Source: UniProtKB <p>Inferred from Expression Pattern</p> <p>Covers cases where the annotation is inferred from the timing or location of expression of a gene.</p> <p>More information in the <a href="http://geneontology.org/page/guide-go-evidence-codes#iep">GO evidence code guide</a></p> Inferred from expression patternⁱ
  • "Downregulation of Ski and SnoN co-repressors by anisomycin."
    Vazquez-Macias A., Ruiz-Mendoza A.B., Fonseca-Sanchez M.A., Briones-Orta M.A., Macias-Silva M.
    FEBS Lett. 579:3701-3706(2005) [PubMed] [Europe PMC] [Abstract]
• response to cytokine Source: Ensembl
• response to growth factor Source: UniProtKBInferred from direct assayⁱ
  • "Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis."
    Nanjundan M., Cheng K.W., Zhang F., Lahad J., Kuo W.L., Schmandt R., Smith-McCune K., Fishman D., Gray J.W., Mills G.B.
    Mol Oncol 2:164-181(2008) [PubMed] [Europe PMC] [Abstract]
• skeletal muscle tissue development Source: UniProtKBInferred from direct assayⁱ
  • "Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation."
    Wrighton K.H., Liang M., Bryan B., Luo K., Liu M., Feng X.H., Lin X.
    J. Biol. Chem. 282:6517-6524(2007) [PubMed] [Europe PMC] [Abstract]
• spermatogenesis Source: Ensembl
• transforming growth factor beta receptor signaling pathway Source: Ensembl

Enzyme and pathway databases

<p>This section provides information about the protein and gene name(s) and synonym(s) and about the organism that is the source of the protein sequence.<p><a href='/help/names_and_taxonomy_section' target='_top'>More...</a></p>Names & Taxonomyⁱ

Organism-specific databases

<p>This section provides information on the location and the topology of the mature protein in the cell.<p><a href='/help/subcellular_location_section' target='_top'>More...</a></p>Subcellular locationⁱ

<p>This section provides information on the disease(s) and phenotype(s) associated with a protein.<p><a href='/help/pathology_and_biotech_section' target='_top'>More...</a></p>Pathology & Biotechⁱ

Organism-specific databases

Polymorphism and mutation databases

<p>This section describes post-translational modifications (PTMs) and/or processing events.<p><a href='/help/ptm_processing_section' target='_top'>More...</a></p>PTM / Processingⁱ

Molecule processing

Amino acid modifications

<p>This subsection of the <a href="http://www.uniprot.org/help/ptm_processing_section">PTM/processing</a> section describes post-translational modifications (PTMs). This subsection <strong>complements</strong> the information provided at the sequence level or describes modifications for which <strong>position-specific data is not yet available</strong>.<p><a href='/help/post-translational_modification' target='_top'>More...</a></p>Post-translational modificationⁱ

<p>UniProtKB Keywords constitute a <a href="http://www.uniprot.org/keywords">controlled vocabulary</a> with a hierarchical structure. Keywords summarise the content of a UniProtKB entry and facilitate the search for proteins of interest.<p><a href='/help/keywords' target='_top'>More...</a></p>Keywords - PTMⁱ

Proteomic databases

PTM databases

<p>This section provides information on the expression of a gene at the mRNA or protein level in cells or in tissues of multicellular organisms.<p><a href='/help/expression_section' target='_top'>More...</a></p>Expressionⁱ

<p>This subsection of the ‘Expression’ section provides information on the expression of a gene at the mRNA or protein level in cells or in tissues of multicellular organisms. By default, the information is derived from experiments at the mRNA level, unless specified ‘at protein level’. <br></br>Examples: <a href="http://www.uniprot.org/uniprot/P92958#expression">P92958</a>, <a href="http://www.uniprot.org/uniprot/Q8TDN4#expression">Q8TDN4</a>, <a href="http://www.uniprot.org/uniprot/O14734#expression">O14734</a><p><a href='/help/tissue_specificity' target='_top'>More...</a></p>Tissue specificityⁱ

Gene expression databases

Organism-specific databases

<p>This section provides information on the quaternary structure of a protein and on interaction(s) with other proteins or protein complexes.<p><a href='/help/interaction_section' target='_top'>More...</a></p>Interactionⁱ

<p>This subsection of the <a href="http://www.uniprot.org/help/interaction_section">'Interaction'</a> section provides information about the protein quaternary structure and interaction(s) with other proteins or protein complexes (with the exception of physiological receptor-ligand interactions which are annotated in the <a href="http://www.uniprot.org/help/function_section">'Function'</a> section).<p><a href='/help/subunit_structure' target='_top'>More...</a></p>Subunit structureⁱ

<p>This subsection of the '<a href="http://www.uniprot.org/help/interaction_section%27">Interaction</a> section provides information about binary protein-protein interactions. The data presented in this section are a quality-filtered subset of binary interactions automatically derived from the <a href="http://www.ebi.ac.uk/intact/">IntAct database</a>. It is updated on a monthly basis. Each binary interaction is displayed on a separate line.<p><a href='/help/binary_interactions' target='_top'>More...</a></p>Binary interactionsⁱ

GO - Molecular functionⁱ

• protein domain specific binding Source: UniProtKBInferred from physical interactionⁱ
  • "ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells."
    Sarker K.P., Kataoka H., Chan A., Netherton S.J., Pot I., Huynh M.A., Feng X., Bonni A., Riabowol K., Bonni S.
    J. Biol. Chem. 283:13269-13279(2008) [PubMed] [Europe PMC] [Abstract]
• SMAD binding Source: UniProtKBInferred from physical interactionⁱ
  • "The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins."
    He J., Tegen S.B., Krawitz A.R., Martin G.S., Luo K.
    J. Biol. Chem. 278:30540-30547(2003) [PubMed] [Europe PMC] [Abstract]
  • "Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts."
    Jinnin M., Ihn H., Mimura Y., Asano Y., Tamaki K.
    Arthritis Rheum. 56:1694-1705(2007) [PubMed] [Europe PMC] [Abstract]

Protein-protein interaction databases

<p>This section provides information on the tertiary and secondary structure of a protein.<p><a href='/help/structure_section' target='_top'>More...</a></p>Structureⁱ

Secondary structure

3D structure databases

Miscellaneous databases

<p>This section provides information on sequence similarities with other proteins and the domain(s) present in a protein.<p><a href='/help/family_and_domains_section' target='_top'>More...</a></p>Family & Domainsⁱ

Coiled coil

<p>This subsection of the ‘Family and domains’ section provides information about the sequence similarity with other proteins.<p><a href='/help/sequence_similarities' target='_top'>More...</a></p>Sequence similaritiesⁱ

Keywords - Domainⁱ

Phylogenomic databases

Family and domain databases

<p>This section displays by default the canonical protein sequence and upon request all isoforms described in the entry. It also includes information pertinent to the sequence(s), including <a href="http://www.uniprot.org/help/sequence_length">length</a> and <a href="http://www.uniprot.org/help/sequences">molecular weight</a>.<p><a href='/help/sequences_section' target='_top'>More...</a></p>Sequences (5+)ⁱ

<p>This subsection of the <a href="http://www.uniprot.org/help/sequences_section">Sequence</a> section indicates if the <a href="http://www.uniprot.org/help/canonical_and_isoforms">canonical sequence</a> displayed by default in the entry is complete or not.<p><a href='/help/sequence_status' target='_top'>More...</a></p>Sequence statusⁱ: Complete.

This entry has 5 described isoforms and 2 potential isoforms that are computationally mapped.Show allAlign All

        10         20         30         40         50
MENLQTNFSL VQGSTKKLNG MGDDGSPPAK KMITDIHANG KTINKVPTVK 
        60         70         80         90        100
KEHLDDYGEA PVETDGEHVK RTCTSVPETL HLNPSLKHTL AQFHLSSQSS 
       110        120        130        140        150
LGGPAAFSAR HSQESMSPTV FLPLPSPQVL PGPLLIPSDS STELTQTVLE 
       160        170        180        190        200
GESISCFQVG GEKRLCLPQV LNSVLREFTL QQINTVCDEL YIYCSRCTSD 
       210        220        230        240        250
QLHILKVLGI LPFNAPSCGL ITLTDAQRLC NALLRPRTFP QNGSVLPAKS 
       260        270        280        290        300
SLAQLKETGS AFEVEHECLG KCQGLFAPQF YVQPDAPCIQ CLECCGMFAP 
       310        320        330        340        350
QTFVMHSHRS PDKRTCHWGF ESAKWHCYLH VNQKYLGTPE EKKLKIILEE 
       360        370        380        390        400
MKEKFSMRSG KRNQSKTDAP SGMELQSWYP VIKQEGDHVS QTHSFLHPSY 
       410        420        430        440        450
YLYMCDKVVA PNVSLTSAVS QSKELTKTEA SKSISRQSEK AHSSGKLQKT 
       460        470        480        490        500
VSYPDVSLEE QEKMDLKTSR ELCSRLDASI SNNSTSKRKS ESATCNLVRD 
       510        520        530        540        550
INKVGIGLVA AASSPLLVKD VICEDDKGKI MEEVMRTYLK QQEKLNLILQ 
       560        570        580        590        600
KKQQLQMEVK MLSSSKSMKE LTEEQQNLQK ELESLQNEHA QRMEEFYVEQ 
       610        620        630        640        650
KDLEKKLEQI MKQKCTCDSN LEKDKEAEYA GQLAELRQRL DHAEADRQEL 
       660        670        680 
QDELRQEREA RQKLEMMIKE LKLQILKSSK TAKE                  

        10         20         30         40         50
MENLQTNFSL VQGSTKKLNG MGDDGSPPAK KMITDIHANG KTINKVPTVK 
        60         70         80         90        100
KEHLDDYGEA PVETDGEHVK RTCTSVPETL HLNPSLKHTL AQFHLSSQSS 
       110        120        130        140        150
LGGPAAFSAR HSQESMSPTV FLPLPSPQVL PGPLLIPSDS STELTQTVLE 
       160        170        180        190        200
GESISCFQVG GEKRLCLPQV LNSVLREFTL QQINTVCDEL YIYCSRCTSD 
       210        220        230        240        250
QLHILKVLGI LPFNAPSCGL ITLTDAQRLC NALLRPRTFP QNGSVLPAKS 
       260        270        280        290        300
SLAQLKETGS AFEVEHECLG KCQGLFAPQF YVQPDAPCIQ CLECCGMFAP 
       310        320        330        340        350
QTFVMHSHRS PDKRTCHWGF ESAKWHCYLH VNQKYLGTPE EKKLKIILEE 
       360        370        380        390        400
MKEKFSMRSG KRNQSKASFL YQFLIMVMVY FEMKILCLVC NLTCMLNIAH 
       410 
ATTTKYRLIY LYCSF                                       

        10         20         30         40         50
MENLQTNFSL VQGSTKKLNG MGDDGSPPAK KMITDIHANG KTINKVPTVK 
        60         70         80         90        100
KEHLDDYGEA PVETDGEHVK RTCTSVPETL HLNPSLKHTL AQFHLSSQSS 
       110        120        130        140        150
LGGPAAFSAR HSQESMSPTV FLPLPSPQVL PGPLLIPSDS STELTQTVLE 
       160        170        180        190        200
GESISCFQVG GEKRLCLPQV LNSVLREFTL QQINTVCDEL YIYCSRCTSD 
       210        220        230        240        250
QLHILKVLGI LPFNAPSCGL ITLTDAQRLC NALLRPRTFP QNGSVLPAKS 
       260        270        280        290        300
SLAQLKETGS AFEVEHECLG KCQGLFAPQF YVQPDAPCIQ CLECCGMFAP 
       310        320        330        340        350
QTFVMHSHRS PDKRTCHWGF ESAKWHCYLH VNQKYLGTPE EKKLKIILEE 
       360        370        380        390        400
MKEKFSMRSG KRNQSKTDAP SGMELQSWYP VIKQEGDHVS QTHSFLHPSY 
       410        420        430        440        450
YLYMCDKVVA PNVSLTSAVS QSKELTKTEA NASISNNSTS KRKSESATCN 
       460        470        480        490        500
LVRDINKVGI GLVAAASSPL LVKDVICEDD KGKIMEEVMR TYLKQQEKLN 
       510        520        530        540        550
LILQKKQQLQ MEVKMLSSSK SMKELTEEQQ NLQKELESLQ NEHAQRMEEF 
       560        570        580        590        600
YVEQKDLEKK LEQIMKQKCT CDSNLEKDKE AEYAGQLAEL RQRLDHAEAD 
       610        620        630 
RQELQDELRQ EREARQKLEM MIKELKLQIL KSSKTAKE              

        10         20         30         40         50
MENLQTNFSL VQGSTKKLNG MGDDGSPPAK KMITDIHANG KTINKVPTVK 
        60         70         80         90        100
KEHLDDYGEA PVETDGEHVK RTCTSVPETL HLNPSLKHTL AQFHLSSQSS 
       110        120        130        140        150
LGGPAAFSAR HSQESMSPTV FLPLPSPQVL PGPLLIPSDS STELTQTVLE 
       160        170        180        190        200
GESISCFQVG GEKRLCLPQV LNSVLREFTL QQINTVCDEL YIYCSRCTSD 
       210        220        230        240        250
QLHILKVLGI LPFNAPSCGL ITLTDAQRLC NALLRPRTFP QNGSVLPAKS 
       260        270        280        290        300
SLAQLKETGS AFEVEHECLG KCQGLFAPQF YVQPDAPCIQ CLECCGMFAP 
       310        320        330        340        350
QTFVMHSHRS PDKRTCHWGF ESAKWHCYLH VNQKYLGTPE EKKLKIILEE 
       360        370        380        390 
MKEKFSMRSG KRNQSKTDAP SGMELQSWYP VIKQEGDHVS QTHSFLHPS  

        10         20         30         40         50
MGDDGSPPAK KMITDIHANG KTINKVPTVK KEHLDDYGEA PVETDGEHVK 
        60         70         80         90        100
RTCTSVPETL HLNPSLKHTL AQFHLSSQSS LGGPAAFSAR HSQESMSPTV 
       110        120        130        140        150
FLPLPSPQVL PGPLLIPSDS STELTQTVLE GESISCFQVG GEKRLCLPQV 
       160        170        180        190        200
LNSVLREFTL QQINTVCDEL YIYCSRCTSD QLHILKVLGI LPFNAPSCGL 
       210        220        230        240        250
ITLTDAQRLC NALLRPRTFP QNGSVLPAKS SLAQLKETGS AFEVEHECLG 
       260        270        280        290        300
KCQGLFAPQF YVQPDAPCIQ CLECCGMFAP QTFVMHSHRS PDKRTCHWGF 
       310        320        330        340        350
ESAKWHCYLH VNQKYLGTPE EKKLKIILEE MKEKFSMRSG KRNQSKTDAP 
       360        370        380        390        400
SGMELQSWYP VIKQEGDHVS QTHSFLHPSY YLYMCDKVVA PNVSLTSAVS 
       410        420        430        440        450
QSKELTKTEA SKSISRQSEK AHSSGKLQKT VSYPDVSLEE QEKMDLKTSR 
       460        470        480        490        500
ELCSRLDASI SNNSTSKRKS ESATCNLVRD INKVGIGLVA AASSPLLVKD 
       510        520        530        540        550
VICEDDKGKI MEEVMRTYLK QQEKLNLILQ KKQQLQMEVK MLSSSKSMKE 
       560        570        580        590        600
LTEEQQNLQK ELESLQNEHA QRMEEFYVEQ KDLEKKLEQI MKQKCTCDSN 
       610        620        630        640        650
LEKDKEAEYA GQLAELRQRL DHAEADRQEL QDELRQEREA RQKLEMMIKE 
       660 
LKLQILKSSK TAKE                                        

Experimental Info

Natural variant

Alternative sequence

Sequence databases

Genome annotation databases

Keywords - Coding sequence diversityⁱ

<p>This section provides links to proteins that are similar to the protein sequence(s) described in this entry at different levels of sequence identity thresholds (100%, 90% and 50%) based on their membership in UniProt Reference Clusters (<a href="http://www.uniprot.org/help/uniref">UniRef</a>).<p><a href='/help/similar_proteins_section' target='_top'>More...</a></p>Similar proteinsⁱ

• 100% Identity
• 90% Identity
• 50% Identity

<p>This section is used to point to information related to entries and found in data collections other than UniProtKB.<p><a href='/help/cross_references_section' target='_top'>More...</a></p>Cross-referencesⁱ

Sequence databases

3D structure databases

Protein-protein interaction databases

PTM databases

Polymorphism and mutation databases

Proteomic databases

Protocols and materials databases

Genome annotation databases

Organism-specific databases

Phylogenomic databases

Enzyme and pathway databases

Miscellaneous databases

Gene expression databases

Family and domain databases

<p>This section provides general information on the entry.<p><a href='/help/entry_information_section' target='_top'>More...</a></p>Entry informationⁱ

<p>This section contains any relevant information that doesn’t fit in any other defined sections<p><a href='/help/miscellaneous_section' target='_top'>More...</a></p>Miscellaneousⁱ

Keywords - Technical termⁱ

Documents

1. SIMILARITY comments
   Index of protein domains and families
2. Human chromosome 3
   Human chromosome 3: entries, gene names and cross-references to MIM
3. Human polymorphisms and disease mutations
   Index of human polymorphisms and disease mutations
4. MIM cross-references
   Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
5. PDB cross-references
   Index of Protein Data Bank (PDB) cross-references
6. Human entries with polymorphisms or disease mutations
   List of human entries with polymorphisms or disease mutations